|
Volumn 26, Issue 26, 2008, Pages 4359-
|
Pseudoprogression in glioblastoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARMUSTINE;
FLUORODEOXYGLUCOSE F 18;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
TEMOZOLOMIDE;
TUMOR PROTEIN;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
DISEASE COURSE;
GLIOBLASTOMA;
HUMAN;
LETTER;
MULTIMODALITY CANCER THERAPY;
NUCLEAR MAGNETIC RESONANCE;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
TUMOR GROWTH;
TUMOR RECURRENCE;
CENTRAL NERVOUS SYSTEM TUMOR;
NOTE;
PATHOPHYSIOLOGY;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
DISEASE PROGRESSION;
GLIOBLASTOMA;
HUMANS;
|
EID: 52049121065
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.18.4440 Document Type: Letter |
Times cited : (51)
|
References (7)
|